September 12th 2024
The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
First link established between human papillomavirus and SCC
June 1st 2006National report - Researchers at Dartmouth Medical Schoolhave for the first time established an association betweeninfection with certain strains of human papillomavirus (HPV) andincreased risk for developing squamous cell carcinoma (SCC).
HPV vaccine approval will lead to several questions
June 1st 2006Washington - A human papilloma virus (HPV) vaccine, based onnoninfectious virus-like particles, could be on the market as earlyas this summer, according to John Schiller, Ph.D., section chief,laboratory of cellular oncology, National Cancer Institute,Bethesda, Md.
Laser, light treatments expanding, combining modalities
June 1st 2006Key developments from the recent American Society for Laser Medicine and Surgery (ASLMS) meeting include broader applications for existing devices and the growing availability of treatments that combine modalities, sources tell Dermatology Times.
Biafine offers innovative wound healing solution
May 1st 2006Las Vegas - The new wound healing product Biafine (OrthoNeutrogena), gaining popularity among radiation oncologists for the treatment of radiation dermatitis, also offers an innovative option for dermatologists in treating problems ranging from sunburn to superficial wounds, according to Diane Berson, M.D., speaking at the annual meeting of the American Society of Cosmetic Dermatology and Aesthetic Surgery here.
Vascular birthmarks: Causes for concern, reasons for hope
May 1st 2006National report - Vascular birthmarks in the pediatricpopulation can create a wide array of questions and concerns forphysicians and parents, says Ilona Frieden, M.D., of the departmentof dermatology, University of California, San Francisco.